170 related articles for article (PubMed ID: 17956820)
1. [Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections].
Cohen R; Grimprel E
Arch Pediatr; 2007 Oct; 14 Suppl 2():S122-7. PubMed ID: 17956820
[TBL] [Abstract][Full Text] [Related]
2. [Child osteoarticular infections: statements and perspectives].
Cohen R; Grimprel E
Arch Pediatr; 2007 Oct; 14 Suppl 2():S79-80. PubMed ID: 17956822
[No Abstract] [Full Text] [Related]
3. [Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].
Cohen R
Arch Pediatr; 2008 Oct; 15 Suppl 2():S53-8. PubMed ID: 19000855
[TBL] [Abstract][Full Text] [Related]
4. Management of osteoarticular infections caused by Staphylococcus aureus is similar to that of other etiologies: analysis of 199 staphylococcal bone and joint infections.
Pääkkönen M; Kallio PE; Kallio MJ; Peltola H
Pediatr Infect Dis J; 2012 May; 31(5):436-8. PubMed ID: 22189524
[TBL] [Abstract][Full Text] [Related]
5. Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant Staphylococcus aureus or Kingella.
Saphyakhajon P; Joshi AY; Huskins WC; Henry NK; Boyce TG
Pediatr Infect Dis J; 2008 Aug; 27(8):765-7. PubMed ID: 18600193
[TBL] [Abstract][Full Text] [Related]
6. [Shorten treatment of in children severe osteomyelitis].
Cohen R
Arch Pediatr; 2007 Oct; 14 Suppl 2():S128-30. PubMed ID: 17956821
[TBL] [Abstract][Full Text] [Related]
7. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
8. [Resistance to antibiotics of Staphylococcus aureus responsible of osteoarticular infections].
Raymond J; Bergeret M
Arch Pediatr; 2007 Oct; 14 Suppl 2():S97-S101. PubMed ID: 17956826
[TBL] [Abstract][Full Text] [Related]
9. [Managing children skin and soft tissue infections].
Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
[TBL] [Abstract][Full Text] [Related]
10. Simplifying the treatment of acute bacterial bone and joint infections in children.
Pääkkönen M; Peltola H
Expert Rev Anti Infect Ther; 2011 Dec; 9(12):1125-31. PubMed ID: 22114963
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus osteoarticular infections in children: an 8-year review of molecular microbiology, antibiotic resistance and clinical characteristics.
Bouras D; Doudoulakakis A; Tsolia M; Vaki I; Giormezis N; Petropoulou N; Lebessi E; Gennimata V; Tsakris A; Spiliopoulou I; Michos A
J Med Microbiol; 2018 Dec; 67(12):1753-1760. PubMed ID: 30351268
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Dosing of Cephalexin for Oral Step-Down Therapy of Pediatric Osteoarticular Infections Caused by Methicillin-Sensitive Staphylococcus Aureus.
Ramchandar N; Arnold J; Cannavino C; Bradley JS
Pediatr Infect Dis J; 2020 Jun; 39(6):523-525. PubMed ID: 32398570
[TBL] [Abstract][Full Text] [Related]
13. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
Adhikari RP; Shrestha S; Barakoti A; Amatya R
BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Toma MB; Smith KM; Martin CA; Rapp RP
Orthopedics; 2006 Jun; 29(6):497-501. PubMed ID: 16786941
[No Abstract] [Full Text] [Related]
15. Community-acquired methicillin-resistant Staphylococcus aureus in bone and joint infections: development of rifampicin resistance.
Donaldson AD; Chan RC; Gosbell IB
Med J Aust; 2006 Feb; 184(4):196. PubMed ID: 16489910
[No Abstract] [Full Text] [Related]
16. Clindamycin combination treatment for the treatment of bone and joint infections caused by clindamycin-susceptible, erythromycin-resistant Staphylococcus spp.
Bonnaire A; Vernet-Garnier V; Lebrun D; Bajolet O; Bonnet M; Hentzien M; Ohl X; Diallo S; Bani-Sadr F
Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115225. PubMed ID: 33099073
[TBL] [Abstract][Full Text] [Related]
17. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of oral cephalexin in children with osteoarticular infections.
Autmizguine J; Watt KM; Théorêt Y; Kassir N; Laferrière C; Parent S; Tapiéro B; Ovetchkine P
Pediatr Infect Dis J; 2013 Dec; 32(12):1340-4. PubMed ID: 23811740
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of daptomycin for MRSA osteomyelitis and joint infection.
Burns CA
Scand J Infect Dis; 2008; 40(2):183-6. PubMed ID: 17852899
[TBL] [Abstract][Full Text] [Related]
20. [Problems with teicoplanin in the treatment of osteoarticular infections caused by methicillin-resistant S. aureus].
Gómez J; Climent C; Herrero F; Ruano L
Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):567-8. PubMed ID: 1489810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
